Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks - Minnesota, April-June 2020.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
18 Sep 2020
Historique:
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 25 9 2020
Statut: epublish

Résumé

SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), can spread rapidly in high-risk congregate settings such as skilled nursing facilities (SNFs) (1). In Minnesota, SNF-associated cases accounted for 3,950 (8%) of 48,711 COVID-19 cases reported through July 21, 2020; 35% of SNF-associated cases involved health care personnel (HCP*), including six deaths. Facility-wide, serial testing in SNFs has been used to identify residents with asymptomatic and presymptomatic SARS-CoV-2 infection to inform mitigation efforts, including cohorting of residents with positive test results and exclusion of infected HCP from the workplace (2,3). During April-June 2020, the Minnesota Department of Health (MDH), with CDC assistance, conducted weekly serial testing at two SNFs experiencing COVID-19 outbreaks. Among 259 tested residents, and 341 tested HCP, 64% and 33%, respectively, had positive reverse transcription-polymerase chain reaction (RT-PCR) SARS-CoV-2 test results. Continued SARS-CoV-2 transmission was potentially facilitated by lapses in infection prevention and control (IPC) practices, up to 12-day delays in receiving HCP test results (53%) at one facility, and incomplete HCP participation (71%). Genetic sequencing demonstrated that SARS-CoV-2 viral genomes from HCP and resident specimens were clustered by facility, suggesting facility-based transmission. Residents and HCP working in SNFs are at risk for infection with SARS-CoV-2. As part of comprehensive COVID-19 preparation and response, including early identification of cases, SNFs should conduct serial testing of residents and HCP, maximize HCP testing participation, ensure availability of personal protective equipment (PPE), and enhance IPC practices

Identifiants

pubmed: 32966272
doi: 10.15585/mmwr.mm6937a3
pmc: PMC7498172
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1288-1295

Investigateurs

Brittney Bailey (B)
Cory Cole (C)
Kathy Como-Sabetti (K)
Richard Danila (R)
Emilio Dirlikov (E)
Kris Ehresmann (K)
Carrie Euerle (C)
Ashley Fell (A)
Rhylee Gilb (R)
Bradley Goodwin (B)
Kelly Hatfield (K)
Nikki Hayes (N)
Lisa Jacobson (L)
Michelle Larson (M)
Gina Liverseed (G)
Leslie Lovett (L)
J P Mahoehney (JP)
Erica Mumm (E)
Nadia L Oussayef (NL)
Sukarma Ss Tanwar (SS)
Sandra Turbes (S)
Jacy Walters (J)

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):882-886
pubmed: 32644985
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
JAMA. 2020 Jul 7;324(1):23-24
pubmed: 32442303
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH